{
    "clinical_study": {
        "@rank": "79027", 
        "arm_group": [
            {
                "arm_group_label": "Standard Treatment", 
                "arm_group_type": "Active Comparator", 
                "description": "A regimen with traditional drugs only"
            }, 
            {
                "arm_group_label": "Incretin-based Treatment", 
                "arm_group_type": "Experimental", 
                "description": "A regimen including incretin-based drugs"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is a pilot randomized controlled trial of 30 elderly type 2 diabetes patients\n      conducted at the MODEL Clinical Research (MODEL), Research Division of Bay West\n      Endocrinology Associates in Baltimore, Maryland. The investigators hypothesized that\n      compared to a regimen base solely on traditional drugs, a regimen including newer drugs will\n      achieve glycemic target faster and induce less hypoglycemia, weight gain, and other side\n      effects, over the short run."
        }, 
        "brief_title": "Glycemia in Diabetic Elders Trial", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 2 Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Type 2 diabetics diagnosed for at least 6 months\n\n          -  Patients ages \u2265 65 years and older\n\n          -  Active patients in the Bay West Endocrinology practice\n\n          -  Inadequately controlled on oral agents and/or basal insulin with HbA1c between 8.0%\n             and 12%\n\n          -  Eligible for randomization to either treatment group\n\n          -  Patients willing to follow either treatment arm including regimen using one or more\n             injectables\n\n          -  Patients to have an English Reading Level of Grade 6 or above\n\n          -  Patients residing at home\n\n        Exclusion Criteria:\n\n          -  Unwilling to use a regimen that may contain using one or more injections\n\n          -  Using short acting insulin prior to the study\n\n          -  Using GLP-1 in past 10 weeks\n\n          -  History of hypoglycemia unawareness or episodes needing emergency intervention\n\n          -  End-stage renal disease\n\n          -  Dementia\n\n          -  Blindness\n\n          -  Terminal illness"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "65 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02029846", 
            "org_study_id": "NA_00052707"
        }, 
        "intervention": [
            {
                "arm_group_label": "Standard Treatment", 
                "description": "traditional drugs only", 
                "intervention_name": "Standard Treatment (insulin, metformin, sulfonylureas, TZDs)", 
                "intervention_type": "Drug", 
                "other_name": [
                    "insulin", 
                    "metformin", 
                    "sulfonylureas", 
                    "TZDs"
                ]
            }, 
            {
                "arm_group_label": "Incretin-based Treatment", 
                "description": "incretin-based drugs", 
                "intervention_name": "Incretin-Based Treatment (GLP-1, DPP-4, amylin analogues)", 
                "intervention_type": "Drug", 
                "other_name": [
                    "GLP-1 analogues and receptor agonists,", 
                    "DPP-4 inhibitors,", 
                    "amylin analogues"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Insulin", 
                "Metformin", 
                "Incretins", 
                "Dipeptidyl-Peptidase IV Inhibitors"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "January 7, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Baltimore", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "21204"
                }, 
                "name": "Bay West Endocrinology Associates"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Glycemia in Diabetic Elders Trial", 
        "other_outcome": {
            "measure": "Diabetes Quality of Life", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "overall_official": {
            "affiliation": "Johns Hopkins University", 
            "last_name": "Hsin-Chieh Yeh, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Time to achieve glycemic target (HbA1c <7.5%).", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02029846"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Johns Hopkins University", 
            "investigator_full_name": "Hsin-Chieh Yeh", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Overall hypoglycemia measured by glucose meter", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "Johns Hopkins University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Johns Hopkins University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}